International Clinical Trial: Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459309) titled 'Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies' on March 4.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Fudan University

Condition: Liver Cancer (Primary and Metastatic) Liver Ablation

Intervention: Device: Multimodal Tumor Thermal Ablation

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 16, 2026

Target Sample Size: 20

Countries of Recruitment...